Literature DB >> 22925150

Functional properties of dopamine neurons and co-expression of vasoactive intestinal polypeptide in the dorsal raphe nucleus and ventro-lateral periaqueductal grey.

Antonios G Dougalis1, Gillian A C Matthews1, Matthew W Bishop1, Frédéric Brischoux1, Kazuto Kobayashi2, Mark A Ungless1.   

Abstract

The dorsal raphe nucleus (DRN) and ventrolateral periaqueductal grey (vlPAG) regions contain populations of dopamine neurons, often considered to be a dorsal caudal extension of the A10 group [mostly found in the ventral tegmental area (VTA)]. Recent studies suggest they are involved in promoting wakefulness and mediate some of the antinociceptive and rewarding properties of opiates. However, little is known about their electrophysiological properties. To address this, we used Pitx3-GFP and tyrosine hydroxylase (TH)-GFP mice to carry out targeted whole-cell recordings from this population in acute brain slices. We found that DRN/vlPAG dopamine neurons have characteristics similar to most VTA dopamine neurons, but distinct from dorsal raphe serotonin neurons. They fire broad action potentials at a relatively slow, regular rate, exhibit a hyperpolarization-activated inward current and delayed repolarization, and show spike-frequency adaptation in response to prolonged depolarization. In addition, they receive fast excitatory and inhibitory synaptic inputs. Moreover, we found co-expression of vasoactive intestinal polypeptide in small, periaqueductal dopamine neurons, but generally not in larger, more ventral dopamine neurons.
© 2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925150      PMCID: PMC4273537          DOI: 10.1111/j.1460-9568.2012.08255.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  55 in total

1.  I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.

Authors:  Henrike Neuhoff; Axel Neu; Birgit Liss; Jochen Roeper
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

2.  Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat.

Authors:  Renata H Hasue; Sara J Shammah-Lagnado
Journal:  J Comp Neurol       Date:  2002-12-02       Impact factor: 3.215

3.  A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system.

Authors:  F A Edwards; A Konnerth; B Sakmann; T Takahashi
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

4.  Dopaminergic neurons in the nucleus raphe dorsalis innervate the prefrontal cortex in the rat: a combined retrograde tracing and immunohistochemical study using anti-dopamine serum.

Authors:  M Yoshida; M Shirouzu; M Tanaka; K Semba; H C Fibiger
Journal:  Brain Res       Date:  1989-09-04       Impact factor: 3.252

5.  Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep.

Authors:  Lionel Dahan; Bernadette Astier; Nicolas Vautrelle; Nadia Urbain; Bernat Kocsis; Guy Chouvet
Journal:  Neuropsychopharmacology       Date:  2006-12-06       Impact factor: 7.853

6.  Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo.

Authors:  K A Allers; T Sharp
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning.

Authors:  Hsing-Chen Tsai; Feng Zhang; Antoine Adamantidis; Garret D Stuber; Antonello Bonci; Luis de Lecea; Karl Deisseroth
Journal:  Science       Date:  2009-04-23       Impact factor: 47.728

8.  Vasoactive intestinal polypeptide afferents to the bed nucleus of the stria terminalis in the rat: an immunohistochemical and biochemical study.

Authors:  L E Eiden; T Hökfelt; M J Brownstein; M Palkovits
Journal:  Neuroscience       Date:  1985-08       Impact factor: 3.590

9.  Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex.

Authors:  Elyssa B Margolis; Hagar Lock; Vladimir I Chefer; Toni S Shippenberg; Gregory O Hjelmstad; Howard L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia.

Authors:  Vladimir Vacic; Shane McCarthy; Dheeraj Malhotra; Fiona Murray; Hsun-Hua Chou; Aine Peoples; Vladimir Makarov; Seungtai Yoon; Abhishek Bhandari; Roser Corominas; Lilia M Iakoucheva; Olga Krastoshevsky; Verena Krause; Verónica Larach-Walters; David K Welsh; David Craig; John R Kelsoe; Elliot S Gershon; Suzanne M Leal; Marie Dell Aquila; Derek W Morris; Michael Gill; Aiden Corvin; Paul A Insel; Jon McClellan; Mary-Claire King; Maria Karayiorgou; Deborah L Levy; Lynn E DeLisi; Jonathan Sebat
Journal:  Nature       Date:  2011-02-23       Impact factor: 49.962

View more
  24 in total

1.  Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.

Authors:  Jean-Francois Poulin; Jian Zou; Janelle Drouin-Ouellet; Kwang-Youn A Kim; Francesca Cicchetti; Rajeshwar B Awatramani
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

Review 2.  Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches.

Authors:  Jean-Francois Poulin; Zachary Gaertner; Oscar Andrés Moreno-Ramos; Rajeshwar Awatramani
Journal:  Trends Neurosci       Date:  2020-02-11       Impact factor: 13.837

3.  Ionic currents influencing spontaneous firing and pacemaker frequency in dopamine neurons of the ventrolateral periaqueductal gray and dorsal raphe nucleus (vlPAG/DRN): A voltage-clamp and computational modelling study.

Authors:  Antonios G Dougalis; Gillian A C Matthews; Birgit Liss; Mark A Ungless
Journal:  J Comput Neurosci       Date:  2017-04-03       Impact factor: 1.621

4.  Molecular and anatomical organization of the dorsal raphe nucleus.

Authors:  Kee Wui Huang; Nicole E Ochandarena; Adrienne C Philson; Minsuk Hyun; Jaclyn E Birnbaum; Marcelo Cicconet; Bernardo L Sabatini
Journal:  Elife       Date:  2019-08-14       Impact factor: 8.140

Review 5.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

6.  Neurochemical differences between target-specific populations of rat dorsal raphe projection neurons.

Authors:  Eric W Prouty; Daniel J Chandler; Barry D Waterhouse
Journal:  Brain Res       Date:  2017-09-01       Impact factor: 3.252

7.  Alcohol effects on synaptic transmission in periaqueductal gray dopamine neurons.

Authors:  Chia Li; Nora M McCall; Alberto J Lopez; Thomas L Kash
Journal:  Alcohol       Date:  2013-04-15       Impact factor: 2.405

8.  Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain.

Authors:  Chia Li; Jonathan A Sugam; Emily G Lowery-Gionta; Zoe A McElligott; Nora M McCall; Alberto J Lopez; Jessica M McKlveen; Kristen E Pleil; Thomas L Kash
Journal:  Neuropsychopharmacology       Date:  2016-01-21       Impact factor: 7.853

9.  Serotonergic versus nonserotonergic dorsal raphe projection neurons: differential participation in reward circuitry.

Authors:  Ross A McDevitt; Alix Tiran-Cappello; Hui Shen; Israela Balderas; Jonathan P Britt; Rosa A M Marino; Stephanie L Chung; Christopher T Richie; Brandon K Harvey; Antonello Bonci
Journal:  Cell Rep       Date:  2014-09-18       Impact factor: 9.423

Review 10.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.